Treatment and developmental therapeutics of Mycobacterium tuberculosis infections
- 1 August 1994
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 4 (3) , 157-173
- https://doi.org/10.1016/0924-8579(94)90005-1
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte dʼIvoireAIDS, 1992
- Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological resultsTubercle and Lung Disease, 1992
- Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 1991
- Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteriaTubercle, 1991
- A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatmentTubercle, 1991
- In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosisTubercle, 1991
- Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experimentsTubercle, 1991
- In vitro activities against mycobacteria of two longacting rifamycins, FCE22807 and CGP40/469A (SPAS-565)Tubercle, 1990
- Susceptibility of Mycobacteria to fusidic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990